End-of-day quote
Shenzhen S.E.
03:30:00 30/04/2024 am IST
|
5-day change
|
1st Jan Change
|
8.23
CNY
|
+3.65%
|
|
+5.11%
|
-13.19%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
8,802
|
12,862
|
10,354
|
7,758
|
6,003
|
Enterprise Value (EV)
1 |
9,142
|
12,510
|
10,956
|
7,909
|
6,471
|
P/E ratio
|
26.3
x
|
11.1
x
|
24
x
|
19.1
x
|
54.4
x
|
Yield
|
2.88%
|
4.33%
|
1.28%
|
0.49%
|
-
|
Capitalization / Revenue
|
3.74
x
|
3.35
x
|
3.54
x
|
1.84
x
|
2.18
x
|
EV / Revenue
|
3.89
x
|
3.26
x
|
3.75
x
|
1.88
x
|
2.35
x
|
EV / EBITDA
|
19.1
x
|
9.33
x
|
20.7
x
|
7.86
x
|
11.8
x
|
EV / FCF
|
-39.1
x
|
13.7
x
|
-155
x
|
7.93
x
|
-25.2
x
|
FCF Yield
|
-2.56%
|
7.31%
|
-0.65%
|
12.6%
|
-3.97%
|
Price to Book
|
4.29
x
|
4.42
x
|
3.76
x
|
2.5
x
|
1.88
x
|
Nbr of stocks (in thousands)
|
6,33,265
|
6,33,265
|
6,33,265
|
6,33,265
|
6,33,265
|
Reference price
2 |
13.90
|
20.31
|
16.35
|
12.25
|
9.480
|
Announcement Date
|
27/04/20
|
15/04/21
|
25/04/22
|
28/04/23
|
29/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,028
|
2,352
|
3,834
|
2,926
|
4,211
|
2,757
|
EBITDA
1 |
396.5
|
478.5
|
1,341
|
530
|
1,006
|
549.3
|
EBIT
1 |
285.8
|
357.7
|
1,200
|
387.6
|
817.1
|
325.3
|
Operating Margin
|
14.1%
|
15.21%
|
31.28%
|
13.25%
|
19.41%
|
11.8%
|
Earnings before Tax (EBT)
1 |
276.4
|
394.2
|
1,339
|
505.5
|
484.9
|
169
|
Net income
1 |
227.8
|
325.8
|
1,158
|
431.2
|
406.8
|
110.4
|
Net margin
|
11.23%
|
13.85%
|
30.19%
|
14.74%
|
9.66%
|
4%
|
EPS
2 |
0.4059
|
0.5295
|
1.828
|
0.6800
|
0.6424
|
0.1743
|
Free Cash Flow
1 |
-415.5
|
-233.6
|
914.3
|
-70.89
|
997.5
|
-257.1
|
FCF margin
|
-20.49%
|
-9.93%
|
23.84%
|
-2.42%
|
23.69%
|
-9.33%
|
FCF Conversion (EBITDA)
|
-
|
-
|
68.19%
|
-
|
99.17%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
78.98%
|
-
|
245.22%
|
-
|
Dividend per Share
2 |
0.1000
|
0.4000
|
0.8800
|
0.2100
|
0.0600
|
-
|
Announcement Date
|
28/04/19
|
27/04/20
|
15/04/21
|
25/04/22
|
28/04/23
|
29/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
764
|
339
|
-
|
603
|
151
|
467
|
Net Cash position
1 |
-
|
-
|
352
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.928
x
|
0.7092
x
|
-
|
1.137
x
|
0.1504
x
|
0.8506
x
|
Free Cash Flow
1 |
-415
|
-234
|
914
|
-70.9
|
998
|
-257
|
ROE (net income / shareholders' equity)
|
18.7%
|
19.2%
|
46.6%
|
15.2%
|
13.8%
|
3.29%
|
ROA (Net income/ Total Assets)
|
6.91%
|
7.38%
|
18.7%
|
4.91%
|
9.5%
|
3.75%
|
Assets
1 |
3,298
|
4,413
|
6,185
|
8,775
|
4,282
|
2,941
|
Book Value Per Share
2 |
2.340
|
3.240
|
4.600
|
4.350
|
4.900
|
5.030
|
Cash Flow per Share
2 |
0.5500
|
0.3800
|
2.060
|
1.070
|
0.8200
|
0.6300
|
Capex
1 |
287
|
233
|
243
|
291
|
398
|
286
|
Capex / Sales
|
14.16%
|
9.89%
|
6.34%
|
9.94%
|
9.45%
|
10.39%
|
Announcement Date
|
28/04/19
|
27/04/20
|
15/04/21
|
25/04/22
|
28/04/23
|
29/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -13.19% | 720M | | +11.40% | 27.92B | | -30.75% | 3.08B | | -15.97% | 2.53B | | +18.11% | 2.47B | | +7.78% | 2.1B | | -9.47% | 1.91B | | -0.56% | 1.51B | | +2.24% | 1.34B | | +3.86% | 1.13B |
Medical Supplies
|